J&S Studies Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: College Station TX United States (1985)

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Clinical Research Coordinator J&S Studies, Inc. | J & S Studies | J&S Studies | J & S Studies, Inc. | J&S Studies, Inc | J&S Studies, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Herpes Labialis (Phase 2)

Impetigo (Phase 2)

Onychomycosis (Phase 2)

Psoriasis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 10